Explains a lot… This would explain why they haven't sold any of their "disruptive" gnr tech. Just starting studies of biocompatibility... what is going on here. The company on multiple occasions mentioned how their gnr tech set them apart from everyone else.
the market sees this nr as another load of fluff.
"This program will seek to substantiate the biocompatibility of Sona's proprietary, gold nanorod manufacturing processes and provide a foundation for further research programs"